Biofrontera Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was USD 0.031 million compared to USD 0.028 million a year ago. Revenue was USD 14.21 million compared to USD 10.6 million a year ago. Net income was USD 4.71 million compared to net loss of USD 7.2 million a year ago. Basic earnings per share from continuing operations was USD 5.2 compared to basic loss per share from continuing operations of USD 18 a year ago. Diluted earnings per share from continuing operations was USD 5.2 compared to diluted loss per share from continuing operations of USD 18 a year ago.